Axon Awarded Nearly $8.84 Million Sole‑Source Contract to Supply TASER 10 Devices to VA Police

Axon Enterprise, Inc. this week finalized a sole‑source contract with the U.S. Department of Veterans Affairs (VA) worth approximately $8,841,031. The contract, awarded under solicitation 36C10D26P0093, covers delivery of TASER 10 conducted energy devices, associated accessories, training, and integration with Axon’s digital evidence management system across 139 VA Police Departments and the Law Enforcement Training Center. PERFORMANCE will span from September 30, 2026, to September 29, 2027.

This contract authorizes provision of roughly 1,700 TASER 10 units with holsters, 197 multi‑bay docking stations, 2,077 battery packs, and approximately 52,000 live, inert, and training cartridges. It also includes the deployment of a federal TASER 10 starter package and the integration of digital evidence services into the VA’s existing Axon Evidence infrastructure. The VA justified Axon as the sole‑source vendor due to the TASER 10’s proprietary ten‑shot capability, individual probe deployment, and integrated laser and telemetry features, along with seamless compatibility with VA’s digital evidence systems—all unmatched by competitors. A corresponding Justification & Approval document was certified and approved on September 18, 2026.

This development was confirmed through official government procurement filings and summarized in recent reporting from GovTribe and Bidscope, both highlighting the contract’s scope, value, timeline, and Axon’s unique position as the sole authorized provider. The award notice was published on October 6, 2026, while the actual contract was awarded on September 29, 2026, with performance beginning the following day.

From an investor perspective, the contract underscores Axon’s continued foothold in the conducted energy devices market and its expanding entrenchment within federal law enforcement operations. While the immediate financial impact is modest relative to Axon’s broader scale, the award strengthens the company’s recurring revenue from digital evidence services and reinforces the operational interoperability of its TASER and Axon Evidence systems.

At the same time, Axon’s stock (ticker: AXON) is trading at a verified price of $417.31, reflecting a 3.15% gain as of October 8, 2026. No direct causation has been confirmed between this specific contract and the equity movement. Investors should view this award as a strategic expansion in government deployment of Axon’s ecosystem, rather than a near‑term market catalyst.

Looking ahead, investors may monitor whether similar awards emerge across other federal or state agencies, and whether Axon can leverage this deployment to cross‑sell broader software and AI services. Additionally, attention to how the TASER 10 and Evidence.com integration scales in volume and digital services could provide insight into recurring revenue trends and ecosystem stickiness going into 2027.